News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
401,929 Results
Type
Article (47710)
Company Profile (133)
Press Release (354086)
Section
Business (116110)
Career Advice (1346)
Deals (16549)
Drug Delivery (38)
Drug Development (50061)
Employer Resources (99)
FDA (7791)
Job Trends (9143)
News (190391)
Policy (14788)
Tag
Academia (2608)
Alliances (33231)
Alzheimer's disease (1118)
Approvals (7780)
Artificial intelligence (83)
Bankruptcy (102)
Best Places to Work (7102)
Biotechnology (84)
Breast cancer (63)
Cancer (704)
Career advice (1125)
Cell therapy (145)
Clinical research (38071)
Collaboration (279)
COVID-19 (1825)
C-suite (53)
Data (716)
Diabetes (80)
Diagnostics (3636)
Drug discovery (50)
Earnings (41957)
Employer resources (88)
Events (49755)
Executive appointments (175)
FDA (8082)
Funding (219)
Gene therapy (103)
GLP-1 (348)
Government (2252)
Healthcare (11086)
Infectious disease (1869)
Inflammatory bowel disease (74)
Interviews (271)
IPO (8023)
Job creations (2300)
Job search strategy (979)
Layoffs (223)
Legal (2630)
Lung cancer (112)
Manufacturing (100)
Medical device (5954)
Medtech (5957)
Mergers & acquisitions (8612)
Metabolic disorders (203)
Neuroscience (1334)
NextGen Class of 2024 (3487)
Non-profit (3619)
Northern California (863)
Obesity (98)
Opinion (121)
Parkinson's disease (78)
Patents (51)
People (32736)
Phase I (11981)
Phase II (16255)
Phase III (12808)
Pipeline (357)
Postmarket research (1850)
Preclinical (6636)
Press Release (66)
Radiopharmaceuticals (154)
Rare diseases (117)
Real estate (4080)
Regulatory (10629)
Research institute (2495)
Resumes & cover letters (189)
Southern California (754)
Startups (2257)
United States (7521)
Vaccines (371)
Weight loss (60)
Date
Today (182)
Last 7 days (686)
Last 30 days (2232)
Last 365 days (21245)
2024 (19154)
2023 (24451)
2022 (34026)
2021 (36028)
2020 (33017)
2019 (27317)
2018 (20500)
2017 (19495)
2016 (19327)
2015 (23086)
2014 (17363)
2013 (15362)
2012 (15442)
2011 (16053)
2010 (14856)
Location
Africa (546)
Arizona (68)
Asia (24791)
Australia (4770)
California (1863)
Canada (745)
China (144)
Colorado (69)
Connecticut (83)
Europe (57964)
Florida (273)
Georgia (63)
Illinois (206)
Indiana (112)
Maryland (308)
Massachusetts (1317)
Michigan (94)
Minnesota (115)
New Jersey (635)
New York (621)
North Carolina (435)
Northern California (863)
Ohio (89)
Pennsylvania (425)
South America (602)
Southern California (754)
Texas (251)
Utah (56)
Washington State (252)
401,929 Results for "purdue research park".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Immunovia streamlines lab operations with move to Research Triangle Park, North Carolina
Immunovia announces that the company will move its lab and U.S. headquarters to Research Triangle Park in North Carolina in May 2024.
April 29, 2024
·
2 min read
Solvias to Build Biologics and Cell & Gene Therapy Testing Center in Research Triangle Park
Solvias announced that it is expanding its global network of laboratory testing centers with a new biotech site in Research Triangle Park, N.C.
May 6, 2024
·
2 min read
Pharm Country
Purdue Pharma L.P. Awards Grant for Investigator-initiated Research to Examine Opioid Overdose Reversal Using Nalmefene HCl Injection
Purdue Pharma L.P. (“Purdue”) announced today that the Company has awarded an investigator-initiated research (IIR) grant to a team of researchers at The University of New Mexico (UNM) for the evaluation of nalmefene hydrochloride (HCl) injection 2mg/2mL (1mg/1mL) in the emergency department setting.
March 27, 2024
·
7 min read
Press Releases
Science 37 Unveils New Corporate Headquarters in Research Triangle Park, NC
August 6, 2024
·
1 min read
Novotech Signs Strategic MOU with Hong Kong-Shenzhen Innovation and Technology Park Limited (HSITPL)
Novotech, the global full-service clinical Contract Research Organization that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, announced it has signed a Memorandum of Understanding with Hong Kong-Shenzhen Innovation and Technology Park Limited.
May 29, 2024
·
4 min read
Research Park at Florida Atlantic University® Announces Headquarters of Surgical Instrument Sterilization Leader
The Research Park at Florida Atlantic University® is pleased to announce that Instrumentum, an emerging leader in the surgical instrument sterilization field has located its headquarters in the Research Park at Florida Atlantic University®
October 12, 2023
·
4 min read
Rosalind Franklin University Innovation and Research Park Welcomes Three Squared Biosciences, Focused on Gut Microbiome Solutions for Chronic Diseases
Rosalind Franklin University of Medicine and Science announces a new tenant in its Innovation and Research Park
November 28, 2023
·
2 min read
Press Releases
Aravax Establishes Pharmaceutical Development base on the Oxford Science Park with a Focus on Developing Manufacturing Capabilities in the UK
November 14, 2024
·
3 min read
BioMidwest
Purdue researcher awarded $1.3 million for malaria drug trials in Southeast Asia and Africa
A Purdue researcher is taking a giant leap forward in the fight against drug-resistant strains of malaria in developing countries.
September 15, 2023
·
5 min read
Ferronova and Purdue Research Foundation (PRF) Sign Licensing Agreement for Use of Fibroblast Activation Protein (FAP) Inhibitor in Radiotherapy
Australian biotech company Ferronova announced today that it has signed a licensing agreement with the Purdue Research Foundation (PRF) for the application of PRF’s patented Fibroblast Activation Protein (FAP) inhibitor in magnetic resonance imaging (MRI) and MRI-guided therapies.
August 23, 2023
·
5 min read
1 of 40,193
Next
